Firma de expresión génica de mal pronóstico y su asociación con la expresión de marcadores inmunofenotípicos de relevancia clínica en pacientes adultos colombianos con LLA-B
Nataly Cruz Rodrígueza,b,c,
, Sandra Quijanod,e, Leonardo Encisoa,f, Jovanny Zabaletag,h, Alba Lucía Combitaa,b,i
Autor para correspondencia
a Programa de Investigación e Innovación en Leucemias Agudas y Crónicas (PILAC), Instituto Nacional de Cancerología, Bogotá D. C., Colombia
b Grupo de Investigación en Biología del Cáncer, Instituto Nacional de Cancerología, Bogotá, Colombia
c Programa de Doctorado en Ciencias Biológicas, Pontificia Universidad Javeriana, Bogotá D. C., Colombia
d Hospital Universitario San Ignacio, Bogotá D. C., Colombia
e Grupo de Inmunobiología y Biología Celular, Departamento de Microbiología, Facultad de Ciencias, Pontificia Universidad Javeriana, Bogotá D. C., Colombia
f Grupo de Hemato-Oncología, Instituto Nacional de Cancerología, Bogotá D. C., Colombia
g Department of Pediatrics, Louisiana State University Health Sciences Center, New Orleans, LA, USA
h Stanley S. Scott Cancer Center, Louisiana State University Health Sciences Center, New Orleans, LA
i Facultad de Medicina, Universidad Nacional de Colombia, Bogotá D. C., Colombia
Ver másLeído
3146
Vecesse ha leído el artículo
934
Total PDF
2212
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 12 | 9 | 7 | 16 |
| 2025 11 | 19 | 32 | 51 |
| 2025 10 | 13 | 14 | 27 |
| 2025 9 | 13 | 16 | 29 |
| 2025 8 | 20 | 11 | 31 |
| 2025 7 | 12 | 7 | 19 |
| 2025 6 | 15 | 7 | 22 |
| 2025 5 | 12 | 3 | 15 |
| 2025 4 | 13 | 4 | 17 |
| 2025 3 | 33 | 6 | 39 |
| 2025 2 | 19 | 3 | 22 |
| 2025 1 | 17 | 4 | 21 |
| 2024 12 | 18 | 6 | 24 |
| 2024 11 | 14 | 3 | 17 |
| 2024 10 | 16 | 8 | 24 |
| 2024 9 | 11 | 4 | 15 |
| 2024 8 | 19 | 7 | 26 |
| 2024 7 | 14 | 4 | 18 |
| 2024 6 | 23 | 10 | 33 |
| 2024 5 | 20 | 5 | 25 |
| 2024 4 | 15 | 7 | 22 |
| 2024 3 | 23 | 19 | 42 |
| 2024 2 | 10 | 9 | 19 |
| 2024 1 | 20 | 15 | 35 |
| 2023 12 | 22 | 28 | 50 |
| 2023 11 | 25 | 8 | 33 |
| 2023 10 | 17 | 12 | 29 |
| 2023 9 | 10 | 1 | 11 |
| 2023 8 | 21 | 5 | 26 |
| 2023 7 | 15 | 14 | 29 |
| 2023 6 | 26 | 4 | 30 |
| 2023 5 | 31 | 9 | 40 |
| 2023 4 | 17 | 4 | 21 |
| 2023 3 | 15 | 3 | 18 |
| 2023 2 | 16 | 4 | 20 |
| 2022 1 | 15 | 9 | 24 |
| 2022 12 | 20 | 7 | 27 |
| 2022 11 | 29 | 11 | 40 |
| 2022 10 | 26 | 15 | 41 |
| 2022 9 | 33 | 26 | 59 |
| 2022 8 | 26 | 19 | 45 |
| 2022 7 | 9 | 12 | 21 |
| 2022 6 | 12 | 9 | 21 |
| 2022 5 | 19 | 8 | 27 |
| 2022 4 | 20 | 8 | 28 |
| 2022 3 | 39 | 12 | 51 |
| 2022 2 | 24 | 3 | 27 |
| 2021 1 | 35 | 16 | 51 |
| 2021 12 | 31 | 7 | 38 |
| 2021 11 | 48 | 9 | 57 |
| 2021 10 | 41 | 10 | 51 |
| 2021 9 | 36 | 13 | 49 |
| 2021 8 | 29 | 7 | 36 |
| 2021 7 | 42 | 7 | 49 |
| 2021 6 | 28 | 7 | 35 |
| 2021 5 | 37 | 10 | 47 |
| 2021 4 | 76 | 20 | 96 |
| 2021 3 | 52 | 7 | 59 |
| 2021 2 | 32 | 7 | 39 |
| 2020 1 | 39 | 13 | 52 |
| 2020 12 | 20 | 9 | 29 |
| 2020 11 | 31 | 11 | 42 |
| 2020 10 | 14 | 10 | 24 |
| 2020 9 | 21 | 5 | 26 |
| 2020 8 | 23 | 7 | 30 |
| 2020 7 | 19 | 5 | 24 |
| 2020 6 | 12 | 7 | 19 |
| 2020 5 | 19 | 16 | 35 |
| 2020 4 | 22 | 8 | 30 |
| 2020 3 | 21 | 6 | 27 |
| 2020 2 | 21 | 10 | 31 |
| 2020 1 | 17 | 8 | 25 |
| 2019 12 | 22 | 8 | 30 |
| 2019 11 | 12 | 4 | 16 |
| 2019 10 | 22 | 7 | 29 |
| 2019 9 | 10 | 7 | 17 |
| 2019 8 | 12 | 12 | 24 |
| 2019 7 | 24 | 19 | 43 |
| 2019 6 | 59 | 19 | 78 |
| 2019 5 | 108 | 67 | 175 |
| 2019 4 | 52 | 19 | 71 |
| 2019 3 | 6 | 7 | 13 |
| 2019 2 | 5 | 6 | 11 |
| 2019 1 | 3 | 4 | 7 |
| 2018 12 | 7 | 3 | 10 |
| 2018 11 | 12 | 2 | 14 |
| 2018 10 | 10 | 6 | 16 |
| 2018 9 | 27 | 7 | 34 |
| 2018 8 | 5 | 7 | 12 |
| 2018 7 | 13 | 3 | 16 |
| 2018 6 | 1 | 5 | 6 |
| 2018 5 | 7 | 1 | 8 |
| 2018 4 | 26 | 2 | 28 |
| 2018 3 | 3 | 1 | 4 |
| 2018 2 | 3 | 0 | 3 |
| 2018 1 | 6 | 0 | 6 |
| 2017 12 | 3 | 1 | 4 |
| 2017 11 | 10 | 1 | 11 |
| 2017 10 | 9 | 3 | 12 |
| 2017 9 | 7 | 1 | 8 |
| 2017 8 | 10 | 1 | 11 |
| 2017 7 | 15 | 1 | 16 |
| 2017 6 | 16 | 21 | 37 |
| 2017 5 | 19 | 7 | 26 |
| 2017 4 | 17 | 5 | 22 |
Mostrar todo
